and other CNS tumors, and other unspecified intracranial neoplasms, respectively. These lists were matched with the epilepsy department's database containing all EEGs conducted at the hospital during this time period. EEG recordings of all matching patients were evaluated to determine if they had NCSE. All patients with NCSE had continuous EEG monitoring. Medical records of the identified patients were reviewed to collect information on demographics, tumor type and treatment, NCSE clinical and EEG characteristics, NCSE treatment, radiography, and overall survival.
Definitions
As of yet, there are no widely accepted criteria for the definition of NCSE. We defined NCSE as ongoing seizure activity, lasting >30 min, without generalized convulsions. Patients were described as being alert or having a depressed (lethargic, obtunded, or comatose) level of consciousness.
Two epileptologists (MF, LM) independently reviewed EEGs and unanimously agreed on inclusion in the study. Seizures were termed subclinical if there was no definite outward manifestation of seizure with the understanding that for some individuals the seizures were depressing the level of consciousness. For the purposes of this review the authors delineate NCSE into four different seizure patterns:
1. Focal nonconvulsive seizures (NCS): A focal onset followed by clear electrographic evolution. A pattern was said to evolve if there were at least 2 unequivocal, sequential changes in frequency, morphology or location as defined by the ACNS guidelines. 11 2. Ictal interictal continuum (IIC): This category was used for ictal patterns without evolution as defined by the ACNS. 11 It is a convention that lateralized periodic discharges (LPD) faster than 3 Hz represent an ictal pattern. 12 In addition, LPD which were slower in frequency with a clinical correlate or which responded to treatment with AEDs were considered a pattern of NCSE.
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Rhythmic or spikey theta and alpha activity without evolution which may wax and wane was placed in this category. Most LPD were NOT considered a form of NCSE. 3. Epilepsia partialis continua (EPC): Defined as unremitting motor seizures involving part or all of one side of the body lasting for hours to days. There is disagreement in the literature regarding the inclusion of this type of seizure under the category of NCSE. Ebersole and Pedley 12 include EPC in the category of NCSE whereas Maganti et al. 4 exclude motor seizures from NCSE.
Since EPC was seen relatively frequently in this population, the authors opted to use Ebersole and Pedley's definition. EPC was often without EEG correlate. 4. Generalized nonconvulsive status epilepticus: Generalized periodic discharges (GPD) 3 Hz or greater on EEG or seizures with a generalized onset and evolution.
The categorization of background EEG characteristics in this paper is described in Table 1 .
Outcomes and statistics
All variables were tested against two outcomes: NCSE duration (greater than or less than 24 h) and 2-month survival. Student's ttests were used for continuous variable and chi-squares and Fisher's exact test were used for categorical variables. Where appropriate, linear-by-linear association was used for graded categorical values. P-values <0.05 were considered significant for this study.
Results
A total of 1101 patients were identified by the queried brain tumor ICD-9 codes. Of these, 259 (24%) had an EEG and 24 (2%) had NCSE.
The reason for the continuous EEG was a clinical seizure for 20 (83%) patients and altered mental status for 4 (17%) patients.
Demographics
There were 12 males and 12 females with a mean age of 62 years (SD 15, range 25-84). Tumor types consisted of 6 primary benign (4 meningioma, 1 acoustic neuroma, 1 central neurocytoma), 10 primary malignant (5 glioblastoma multiforme, 1 high grade glioma, 2 WHO III anaplastic astrocytoma, 1 WHO grade II astrocytoma, 1 oligodendroglioma), and 8 secondary malignant (4 lung cancer, 1 breast cancer, 1 multiple myeloma, 1 oral pharynx, 1 unknown primary).
Five patients (21%) had NCSE lasting less than 24 h while 19 patients (79%) had NCSE for greater than 24 h. Eleven (48%) patients died within 2 months of their episode of NCSE (data missing for one patient). Age, gender, and tumor type were not associated with 24-h NCSE duration or 2-month survival.
Median survival time from first onset of NCSE was 3 months for primary benign, 1.9 months for primary malignant, and 1.2 months for secondary malignant. Median survival time from tumor diagnosis was 84 months for primary benign, 18 months for primary malignant, and 1.2 months for secondary malignant.
NCSE clinical characteristics
Mental status exam showed 2 patients in coma, 10 patients with obtunded or lethargic mental status, and 12 alert patients. Alert patients were more likely to have NCSE duration of greater than 24 h (p = 0.002), however there was no effect on 2-month survival.
Motor signs (either jerking/twitching or automatisms) were observed in 10/24 (42%) patients and were nearly significantly correlated with NCSE duration of greater than 24 h (p = 0.053) but were not associated with improved or worsened 2-month survival. Seven of these 10 patients had EPC. Motor manifestations were more common in the alert patients with 8/12 alert patients having motor manifestations. Four patients had language disturbances during their NCSE. For 2 of these 4 patients, the language disturbance was a persistent aphasia which gradually improved (over the course of days) with treatment of NCSE. All of the patients with a language disturbance were alert, as language could not be reasonably assessed in patients with lethargy, obtundation or coma.
The vast majority of the seizures captured were subclinical. Of the 24 patients, 5 (21%) had clinical seizures only, 6 (25%) had clinical and subclinical seizures, and 13 (54%) had only subclinical seizures. For the 6 patients with both clinical and subclinical seizures, time spent in subclinical status was far longer than the time spent with clinical seizures. All of the 12 patients with a depressed level of consciousness had subclinical seizures. Seven of the 12 patients with an alert mental status had subclinical seizures. Fig. 1 shows a comparison between the clinical characteristics of NCSE in alert patients and in those with a depressed level of consciousness.
Five out of 24 (22%) patients were intubated, however there was no association with NCSE duration or survival.
NCSE EEG characteristics
Twelve patients had numerous focal NCS, 10 had NCSE on the IIC, 7 had EPC, and 3 had seizures with a generalized onset (Fig. 2) . Seven people had more than one seizure pattern. Two of the 7 patients with EPC had a definite electrographic correlate (a time locked LPD) with each jerk.
Eleven patients had seizures classified as on the IIC. Details of the seizure patterns can be found in Table 2 . Electrographically, continuous LPD and rhythmic/spikey activity without evolution were placed in this category. The cessation of this activity tended to be gradual without a discreet electrographic offset. Clinical improvement correlated with the electrographic improvement.
More severe generalized slowing (p = 0.017), poorer organization (p = 0.024) and non-reactive EEG (p < 0.001) were associated with less than 24-h NCSE duration. No EEG characteristics were correlated with 2-month survival.
NCSE treatment
Patients whose NCSE lasted for more than 24 h had more AEDs at onset (1.4 vs. 0.6, p = 0.037) and more AEDs during treatment (3.2 vs. 2.0, p = 0.033) of NCSE. AED use was not associated with 2-month survival. Specific AEDs used are detailed in Fig. 3 .
Treatment with benzodiazepines, steroids, or continuous midazolam infusion was not associated with 2-month mortality or NSCE duration.
Of the 24 people, treatment resolved the NCSE in 22 (92%). Eighteen (75%) people showed both resolution of the seizures and improvements in their clinical exam. Four individuals' (17%) EEG's improved with treatment, but their mental status did not improve. Two (8%) people did not improve clinically or electrographically. Treatment was essentially interrupted for both of these patients, one for emergency neurosurgery, and the second for a transfer to palliative care.
Radiographic findings
In the 6 patients with primary benign tumors, 5 had stable tumors on MRI (missing data for 1 patient). NCSE occurred in the post-operative period in 4/6 of these patients. Of the 10 patients with primary malignant disease, 4 had stable tumors, 5 had progressive tumors, and 1 presented with a new malignant lesion. Among the 8 patients with metastatic cancer, only 1 had stable disease while 6 showed new brain lesions and 1 did not have prior MRI on record for comparison in the setting of established metastases.
Having a new or progressing lesion on MRI was associated with a decreased 2-month survival (p = 0.030). Patients with new or progressing lesions had 75% (9/12) mortality at two months, while those with stable disease had a two-month mortality of 20% (2/10).
Discussion
This is one of the first studies, and the largest to date, to examine NCSE in patients with brain tumors. In this study, NCSE was found in 2% of all patients with brain tumors admitted to Mount Sinai Hospital over a three-year period.
Nineteen (79%) out of 24 patients with NCSE had subclinical seizures, including all 12 patients with a depressed level of consciousness. Six of these 19 patients had both subclinical and clinical seizures. This suggests that we underestimate NCSE, as we cannot rely on outward manifestation of seizure activity for detection. Furthermore, clinical seizures represent the tip of the iceberg in terms of seizure activity.
NCSE duration of greater than 24 h was statistically associated with a number of findings including: (1) a more alert mental status, (2) less generalized slowing on EEG, (3) better EEG organization, (4) a reactive EEG, (5) presence of motor signs during seizure activity, (6) more AEDs at onset of NCSE, and (7) more AEDs during NCSE treatment. Despite the NCSE, these patients were not intubated and a medication induced coma was not initiated. This is likely because the risk/benefit analysis by the treating team was deemed to favor a more conservative, less aggressive management, perhaps because these patients were alert with well organized EEGs. A greater number of AEDs at onset and during treatment indicates that these patients may have had previously established epilepsy that was more treatment resistant. This supports Brophy et al.'s description of two clinical phenotypes in NCSE: NCSE in the context of previously established epilepsy and NCSE with severely impaired mental status in an acutely ill patient. 13 Continuous motor seizures, particularly EPC, are known to be refractory to treatment, 14 therefore it is not surprising that seizures with motor signs lasted more than 24 h and that more AEDs were used to gain control. Not uncommonly 4 or more medications are tried in these patients.
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The 2-month mortality of patients with NCSE was 48%. The most important difference between patients who died within 2 months of NCSE and those who lived, in many cases, well beyond 2 months was the presence of new or progressing brain lesions on MRI. An astounding 75% of patients with new or progressing brain lesions died within 2 months. Many studies have described status epilepticus as a presenting sign of a new or progressing lesion 9, 16, 17 but this is the first to note its strong negative implications for survival. Neuroimaging is warranted in patients with NCSE with a history of brain tumor and in patients with NCSE with no discernible cause.
NCSE may also be associated with decreased survival time from tumor diagnosis. Patients with primary malignant tumors had a median survival time of 18 months, which at first glance seems consistent with historical data for GBM. However, in this study, only 5/10 patients with primary malignant tumors had GBM while the other 5 had grade II or grade III gliomas, possibly indicating that survival may be negatively affected by the presence of NCSE. Those with secondary malignant tumors had a median survival of only Fig. 3 . Anti-epileptic drugs.
1.2 months, less than the expected range 2.6-11.0 months for metastatic brain tumors. 18 Although the sample size is small, it indicates a trend toward NCSE being a poor prognostic factor for overall survival in all tumor types, particularly in metastatic brain lesions. This could be due to NCSE synergistically affecting the outcome, as has been found in a stroke and status epilepticus population, 19 or it may be that NCSE is a herald for advancing disease with no direct impact on survival. This data suggests that NCSE is highly treatable in this population. The NCSE resolved in 22 of the 24 patients with improvement in overall level of function in 18 of the 24 patients. Even outside of overall prognosis, diagnosis and treating NCSE may be an important way to improve quality of life.
This study underscores the importance of recognizing NCSE in the brain tumor population. With proper EEG screening of highrisk patients in a hospital setting, NCSE can be more readily identified. Given this data, all patients with a depressed level of consciousness and a brain tumor should be considered at risk for NCSE. Identifying NCSE is critical as it is a reversible cause of impaired mental status.
This study has a number of limitations. The main one is the relatively small sample size, as it provides limited statistical power to find differences and precludes more complex multivariate regression analysis. The second limitation is that this is a retrospective design, which hinders the ability to understand outcomes. In this review, NCSE resolved in a high percentage of the patients with treatment (92%). Most (75%) of the patients improved clinically as well. However, without a double blind randomized design, conclusions regarding the benefit of treating NCSE are difficult to draw. The third limitation of this paper is the referral bias. The majority of the patients in NCSE were referred for continuous EEG because of a clinical seizure. Once connected to VEEG, the vast majority of seizures were subclinical. All of the patients with a depressed level of consciousness had subclinical seizures. A reasonable avenue for further research is a prospective trial designed to determine with continuous EEG the incidence of NCSE in brain tumor patients with a depressed level of consciousness. A prospective continuous EEG trial on brain tumor patients with altered mental status would aid in the determination of the impact NCSE has on morbidity and mortality.
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